1. 631PNeoadjuvant therapy for esophageal adenocarcinoma: A propensity score-matched comparison of paclitaxel and carboplatin chemoradiotherapy with cisplatin and 5-fluoruracil-based chemo- or chemoradiotherapy. (23rd October 2018) Authors: Barbour, A P; Brosda, S; Wijnhoven, B; van Hootgem, S; Lanschot, J J B; Barbour, S; Lagarde, S; Krause, L; Pryor, D; Thomas, J; Walpole, E T; van der Gaast, A; Smithers, M Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Baseline neutrophil–lymphocyte ratio holds no prognostic value for esophageal and junctional adenocarcinoma in patients treated with neoadjuvant chemotherapy. Issue 6 (2nd November 2019) Authors: van Hootegem, S J M; Smithers, B M; Gotley, D C; Brosda, S; Thomson, I G; Thomas, J M; Gartside, M; Barbour, A P Journal: Diseases of the esophagus Issue: Volume 33:Issue 6(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Complications and survival after hybrid and fully minimally invasive oesophagectomy. Issue 1 (11th February 2021) Authors: Veenstra, M M K; Smithers, B M; Visser, E; Edholm, D; Brosda, S; Thomas, J M; Gotley, D C; Thomson, I G; Wijnhoven, B P L; Barbour, A P Journal: BJS open Issue: Volume 5:Issue 1(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Complications and survival after hybrid and fully minimally invasive oesophagectomy. Issue 1 (11th February 2021) Authors: Veenstra, M M K; Smithers, B M; Visser, E; Edholm, D; Brosda, S; Thomas, J M; Gotley, D C; Thomson, I G; Wijnhoven, B P L; Barbour, A P Journal: BJS open Issue: Volume 5:Issue 1(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗